期刊文献+

脑脊液神经蛋白质对临床拟诊Creutzfeldt—Jakob病的早期诊断价值 被引量:9

The early diagnostic value of neuroproteins in the cerebrospinal fluid for possible Creutzfeidt-Jakob disease
原文传递
导出
摘要 目的探讨和比较数种神经蛋白质对 Creutzfeldt-Jakob 病(CJD)的早期诊断价值。方法对14例发病2个月内 CJD 取脑脊液,采用蛋白捕捉法和酶联免疫试验对总 tau 蛋白(t-tau)、磷酸化 tau 蛋白(p-tau)、t-tau 蛋白与 p-tau 蛋白比值(t-tau/p-tau)、S-100β蛋白、14-3-3蛋白及14-3-2蛋白进行定量检测,同时设非 CJD 痴呆(OD,11例)和无痴呆(ND,18例)的对照组。结果 (1)t-tau蛋白:CJD 组、OD 组和 ND 组分别是8295、300、161 pg/ml。p-tau/t-tau 值分别是0.0092、0.2258、0.2471。(2)S-100β蛋白:CJD 组、OD 组、ND 组分别是1.576、0.639、0.239 ng/ml。(3)14-3-3蛋白:CJD 组、OD 组、ND 组分别是40.00、2.65、3.10 ng/ml。(4)14-3-2蛋白:CJD 组、OD 组与 ND 组分别是48.43、14.00、20.50 ng/ml。(5)t-tau≥500 pg/ml 为阈值点,敏感度为84.6%,特异度87.5%,p-tau 无诊断意义;(6)S-100B 蛋白≥1.626 ng/ml 为阈值点,敏感度为92.3%,特异度为83.8%;(7)14-3-3蛋白以≥9 ng/ml 为阈值点,敏感度为86.7%,特异度为86.4%;(8)14-3-2蛋白以≥24 ng/ml 为阈值点,其敏感度为78.6%,特异度为77.3%。结论脑脊液神经蛋白质检测对散发性 Creutzfeldt-Jakob病的早期诊断有一定价值。 Objective To inquire and compare the value of 4 proteins in the cerebrospinal fluid (CSF) for early diagnosis of Creutzfeldt-Jakob disease (CJD). Methods The CSF samples were obtained from 14 CJD patients in the early stage, t-tan, p-tan, t-tau/p-tau, S-100β, 14-3-3 and 14-3-2 protein had been examined and compared with other dementia (OD) and none dementia (ND) as controls by capture assay and ELISA. Results ( 1 ) t-tau protein: the concentration in CJD , OD and ND is 8295, 300 and 161 pg/ml respectively, p-tau/t-tau ratio is 0. 0092,0. 2258 and 0. 2471 respectively. (2) S-100β protein: the concentration in CJD, OD and ND is 1. 576, 0. 639 and 0. 239 ng/ml respectively. (3) 14-3-3 protein : the concentration in CJD,OD and ND is 40. 00,2. 65 and 3.10 ng/ml respectively. (4) 14-3-2 protein: the concentration in CJD, OD and ND is 48. 43,14. 00 and 20. 50 ng/ml respectively. (5) At the cut-off point 500 pg/ml for t-tan, sensitivity for diagnosis of CJD is 84.6% and specificity is 87.6%, p-tau has no diagnostic value to CJD, ( 6 ) At 1. 626 ng/ml for S-100β, the sensitivity is 92. 3% and specificity is 83.8%. (7) At 9 ng/ml for 14-3-3 protein,the sensitivity is 86. 7% and specificity is 86.4%. (8) At a level of 24 ng/ml for 14-3-2 protein, the sensitivity for diagnosis of CJD is 78.6% and specificity is 77. 3%. Conclusion It is the CSF detection of neuroproteins that have great valuble significance in diagnosis for sporadic CJD in the early stage.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2007年第4期253-256,共4页 Chinese Journal of Neurology
基金 国家自然科学基金(30470589)
关键词 克-亚综合征 14-3-3蛋白质类 TAU蛋白质类 S100蛋白质类 早期诊断 Creutzfeldt-Jakob syndrome 14-3-3 protein tau protein Antigen S100β Early diagnosis
  • 相关文献

参考文献11

  • 1Goodall CA, Head MV, Everington D, et al. Raised CSF phosphotan concentrations in variant Creutzfeldt-Jakob disease: diagnostic and pathological implications. J Neurol Neurosurg Psychiatry, 2006,77:89-92.
  • 2Buerger K, Otto M, Teipel SJ, et al. Dissociation between CSF total tan and tau protein phosphorylated at threonine 231 in Creutzfeldt- Jakob disease. Neurobiol Aging, 2006,27 : 10-15.
  • 3Blennow K,Johansson A,Zetterberg H. Diagnostic value of 14-3-3 beta immunoblot and T-tan/P-tan ratio in clinically suspected Creutzfeldt-Jakob disease. Int J Mol Med,2005,16: 1147-1149.
  • 4van Everbroeck B, Boons J, Cras P. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease. Clin Neurol Neurosurg, 2005,107 : 355 -360.
  • 5Blennow K, Lind B, Andersson E, et al. CSF-analyses in clinical diagnosis of Creutzfeldt-Jakob disease. Lakartidningen, 2001,98 : 2446 -2451.
  • 6Kovaes GG, Voigtlander T, Gelpi E, et al. Rationale for diagnosing human prion disease. World J Biol Psychiatry,2004,5: 83-91.
  • 7Burkhard PR, Sanchez JC, Landis T, et al. Cerebrospinal fluid detection of 14-3-3 proteins in unselected patients with dementia. Neurology, 2001,56 : 1528-1533.
  • 8Zanusso G, Righetti PG, Ferrari S, et al. Two-dimensional mapping of three phenotype-associated isforms of prion protein in sporadic Creutzfeldt-Jakob disease. Electrophoresis, 2002,23 : 347- 355.
  • 9Otto M, Wilffang J, Cepek L, et al. Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology ,2002,58 : 192-197.
  • 10Geschwind MD, Martindale J, Miller D, et al. Challenging the clinical utility of 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Arch Neurol, 2003, 60:813-816.

同被引文献103

引证文献9

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部